Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRX.L Regulatory News (CRX)

  • There is currently no data for CRX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) Cyprotex Plc

2 Nov 2016 10:09

RNS Number : 1336O
Nplus1 Singer Capital Markets Ltd
02 November 2016
 

FORM 8.5 (EPT/RI)

 

This disclosure replaces RNS 4994N which was disclosed in error.

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Cyprotex Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Cyprotex Plc

 

(d) Date dealing undertaken:

01 November 2016

 

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

If YES, specify which:

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 1P

 

Purchase

 

11653

 

 

156.64p

 

156.64p

 

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

02 November 2016

Contact name:

Damian Fernandez

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERBTBMTMBMMBFF
Date   Source Headline
10th Oct 20169:03 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
7th Oct 20169:36 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
6th Oct 20165:15 pmRNSConversion of Loan Notes & TVR
6th Oct 20167:00 amRNSNew DDI-Fusion
5th Oct 20169:11 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
3rd Oct 20169:50 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
30th Sep 20169:26 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
29th Sep 20169:42 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
27th Sep 20169:34 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
26th Sep 201610:02 amRNSForm 8.3 - Cyprotex Plc
26th Sep 20169:25 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
26th Sep 20167:00 amRNSAppointment of new Director of US Operations
23rd Sep 20169:10 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
21st Sep 20169:29 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
20th Sep 20169:09 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
19th Sep 20169:42 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
16th Sep 20163:52 pmRNSForm 8.3 - Cyprotex plc
16th Sep 20169:36 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
15th Sep 201610:33 amRNSForm 8.3 - Cyprotex plc
15th Sep 201610:05 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
13th Sep 20169:33 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
13th Sep 20167:00 amRNSExtension of metabolite identification service
12th Sep 201612:31 pmRNSForm 8.3 - Cyprotex plc
9th Sep 20169:15 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
8th Sep 20167:00 amRNSExpansion ADME capabilities (8 transporter assays)
7th Sep 20169:43 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
6th Sep 201610:08 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
2nd Sep 20169:12 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
1st Sep 20169:31 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
31st Aug 20169:47 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
30th Aug 20169:28 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
26th Aug 20169:34 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
25th Aug 20169:39 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
25th Aug 20167:00 amRNSInstallation of two mass spectrometer systems
23rd Aug 20169:39 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
22nd Aug 201610:01 amRNSForm 8.5 (EPT/RI)
17th Aug 201611:24 amRNSForm 8.3 - Cyptotex Plc
17th Aug 20169:39 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
16th Aug 20169:25 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
15th Aug 201610:52 amRNSForm 8.3 - Cyprotex Plc
15th Aug 20169:13 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
12th Aug 20169:29 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
11th Aug 20169:15 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
10th Aug 201611:14 amRNSForm 8.3 - Cyprotex Plc
10th Aug 20169:14 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
9th Aug 20169:14 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
8th Aug 201611:10 amRNSForm 8.3 - Cyprotex
8th Aug 20169:29 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
5th Aug 201611:00 amRNSForm 8.3 - Cyprotex Plc
5th Aug 20169:32 amRNSForm 8.3 - Cyprotex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.